非酒精性脂肪肝炎的临床研究进展

李国钦

非酒精性脂肪肝炎的临床研究进展

李国钦

北海市人民医院广西北海536000

详细信息

中图分类号: R575.1
计量
- 文章访问数: 3124
- HTML全文浏览量: 4
- PDF下载量: 816
- 被引次数: 0
出版历程
- 出版日期: 2004-02-20

Li GuoQin

摘要

HTML全文

参考文献(15)

[1] Ludiwig J, Mcgill DB, Lindor KD. Nonalcoholic steatohepatitis[J].J Gastroenterology Hepatology, 1997, 129∶398-403.

[2] ChitturiS , FarrellGC .EtiopathogenesisofNonalcoholicSteatohepatiti[J].SeminarsinLiverDisease, 2001, 21∶27-42.

[3] Younossi ZM, Diehl AM, Ong JP. Nonalcoholic Fatty Liver Disease: An Agenda for Clinical Reseach[J]. Hepatology, 2002, 35∶746-752.

[4] Garcia-Monzon C, Martin-Perez E, Iacono OL, et al. Character of Pathogenic and Prognostic Factors of Nonalcoholic Steatohepatitis Associated With Obesity[J].J Hepatology, 2000, 33∶716-724.

[5] Brunt EM. Nonalcoholic Steatohepatitis: Definition and Pathlogy[J]. Seminars in Liver Disease, 2001, 21 (1) ∶3-16.

[6] Matteoni CA, Younossi ZM, Gramlich T, et al. Nonalcoholic Fatty Liver Disease: A Spectrum of Clinical and Pathological Severty[J].Gastroenterology, 1999, 116∶1413-1419.

[7] Galdwell SH, Hespenheide EE. Subacute Liver Failure in Obese Women[J].AM J Gastroenterology, 2001, 97 (8) ∶2058-2062.

[8] Marchesini G, Forlani G. NASH: From Liver Disease to Metabalic Disorders and Back to Clinical Hepatology[J].Hepatology, 2002, 35∶497-499.

[9] Marrero JA, Fontana RJ, Su GL, et al. NAFLD may be a Common Underlying Liver Disease in Patients With Hepatocellular Carcinoma in the United States[J].Hepatology, 2002, 36∶1349-1354.

[10] Charlton M, Sreekumar R, Rasmuaaen D, et al. Apolipoprotein Synthesis in nonalcoholic steatohepatitis [J].Hepatology, 2002, 35∶898-904.

[11] Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: Association of insulin Resistance and Mitochondrial Abnormalities[J].Gastroenterology, 2001, 120∶1183-1192.

[12] Day CP. NASH-related Liver Failure: One hit too many?[J].Am J Gastroenterology, 2001, 97∶1872-1874.

[13] Anania FA, Leptin. FA, Liver and Obese Mice Fibrosis in the Fat Lone[J].Hepatology, 2002, 36∶246-247.

[14] Chitturi S, Farre G, Kriketos A, et al. Serum Leptin in NASH Correlates with hepatic steatosis but not fibrosis: A Manifestation of lipoxicity?[J].Hepatology, 2002, 36∶403-409.

[15] Li ZP, Yang SQ, Lin HZ, et al. Probiotics and Antibodies to TNF Inhibit Inflammatory Activity and Improve Nonalcoholiuc Fatty Liver Disease[J]. Hepatology, 2003, 37∶343-350.

施引文献

资源附件(0)

访问统计